<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01885130</url>
  </required_header>
  <id_info>
    <org_study_id>GLI.04.SRE.US10232a</org_study_id>
    <nct_id>NCT01885130</nct_id>
  </id_info>
  <brief_title>Patch Test Skin Irritation/Sensitization of Cetaphil Daily Advance Ultra Hydration Lotion</brief_title>
  <official_title>100 Human Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Occlusive Patch)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Galderma Laboratories, L.P.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Galderma Laboratories, L.P.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Determine if Cetaphil Daily Advance Ultra Hydrating Lotion proves to be a contact sensitizer
      or irritant in certain individuals.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>area of erythema and edema is measured</measure>
    <time_frame>3 consecutive weeks</time_frame>
    <description>9 consecutive 24hr exposures for every Monday, Wednesday, and Friday for 3 consecutive weeks</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Determine Sensitivity of Skin to Cetaphil Daily Advance Ultra Hydrating Lotion</condition>
  <arm_group>
    <arm_group_label>Cetaphil Daily Advance Ultra Hydrating Lotion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects receive Cetaphil Daily Advance Ultra Hydrating Lotion</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cetaphil Daily Advance Ultra Hydrating Lotion</intervention_name>
    <description>0.2ml or 0.2g of Cetaphil on occlusive, hypoallergenic patch applied to skin for 24 hrs 9 times on Monday, Wednesday, and Friday for 3 weeks</description>
    <arm_group_label>Cetaphil Daily Advance Ultra Hydrating Lotion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Not currently under a doctor's care

          -  Free of dermatological or systemic disorder which would interfere with the results

          -  Free of any acute or chronic disease

          -  Will complete a preliminary medical history form and are in general good health

          -  Can read, understand, and sign informed consent

        Exclusion Criteria:

          -  Under 18 years old

          -  Currently under doctor's care

          -  currently taking any medication

          -  History of acute or chronic disease

          -  Diagnosed with chronic skin allergies

          -  Pregnant or lactating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mayya Tastene, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AMA Laboratories</affiliation>
  </overall_official>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2013</study_first_submitted>
  <study_first_submitted_qc>June 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2013</study_first_posted>
  <last_update_submitted>June 19, 2013</last_update_submitted>
  <last_update_submitted_qc>June 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dimenhydrinate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

